Melanoma

Latest Posts

Knowledge from the IGNYTE major analysis reveals clinically significant exercise throughout all subgroups, together...

Market

Replimune Presents Main Evaluation Knowledge from IGNYTE Scientific Trial of RP1 Mixed with Nivolumab in Anti-PD1 Failed Melanoma at European Society for Medical Oncology...